Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Total Non-Current Liabilities (2020 - 2025)

BioAtla (BCAB) has 6 years of Total Non-Current Liabilities data on record, last reported at $27.3 million in Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 40.47% year-over-year to $27.3 million; the TTM value through Sep 2025 reached $27.3 million, up 40.47%, while the annual FY2024 figure was $34.3 million, 17.7% up from the prior year.
  • Total Non-Current Liabilities reached $27.3 million in Q3 2025 per BCAB's latest filing, down from $41.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $41.6 million in Q2 2025 and bottomed at $17.5 million in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $28.2 million, with a median of $27.8 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: tumbled 50.55% in 2024, then skyrocketed 138.5% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $23.8 million in 2021, then increased by 7.55% to $25.6 million in 2022, then grew by 14.02% to $29.2 million in 2023, then increased by 17.7% to $34.3 million in 2024, then dropped by 20.4% to $27.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $27.3 million in Q3 2025, $41.6 million in Q2 2025, and $35.8 million in Q1 2025.